chevron_leftBack
As of 24 April 2025, CS Diagnostics Corp. has a market cap of $15.38M USD, ranking #31191 globally and #365 in Germany. It ranks #3131 in the Healthcare sector, and #398 in the Medical Devices industry.
Key Stats
Market Cap
$15.38MUSD
EBITDA (TTM)
-$295.95KUSD
Net Income (TTM)
-$341.61KUSD
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Thomas Fahrhöfer
open_in_new
Employees
1
Founded
1996
Website
cs-diagnostics.de
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| -38% | 64% | -49% | -84% | -60% | -36% |
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
CSDX
CS Diagnostics Corp
ISIN: US33852L2025
Shares Out.:
Shares Outstanding:
270.574K1
Shares Float:
270.574K2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
0.0700 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About CS Diagnostics Corp.
CS Diagnostics Corp. manufactures and sells medical products for medicine, radiology, cardiology, and radiation therapy in Germany and internationally. The company offers injectors, pistons, hose systems, PCR tests, medicines, and gloves. It also operates as a pharmaceutical wholesaler. The company was formerly known as FlashZero Corp. and changed its name to CS Diagnostics Corp. in August 2023. The company was incorporated in 1996 and is based in Neuss, Germany.
